View the GLIPITA M 50/500 registration information details.
Back to drug list
ItemsDrug Registration information
ID2843
No2843
Brand NameGLIPITA M 50/500
IngredientsSITAGLIPTIN PHOSPHATE MONOHYDRATE BP 64.250 MG EQ. TO SITAGLIPTIN 50 MG, METFORMIN HYDROCHLORIDE BP 500 MG
Dosage FormTABLET
Primary PackagingALU-PVDC BLISTER
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 1 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsAS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIA CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionAN ORANGE COLORED, OBLONG SHAPED CORE TABLET ENGRAVED BPL ON ONE SIDE AND PLAIN ON THE OTHER
Note
License OwnerVIMPEX (LAO) CO.,LTD
ManufacturerBEXIMCO PHARMACEUTICALS LTD
CountryBANGLADESH
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No10 I 4612/18
FDD Registration Date08/01/2024
Expiry Date07/01/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA